A Nine year follow up study of renal effects in workers exposed to cadmium in a zinc ore refinery
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
<record>
<leader>00000nab a2200000 i 4500</leader>
<controlfield tag="001">MAP20071015277</controlfield>
<controlfield tag="003">MAP</controlfield>
<controlfield tag="005">20080418114137.0</controlfield>
<controlfield tag="007">hzruuu---uuuu</controlfield>
<controlfield tag="008">931104e19930701gbr|||| | |00010|eng d</controlfield>
<datafield tag="040" ind1=" " ind2=" ">
<subfield code="a">MAP</subfield>
<subfield code="b">spa</subfield>
</datafield>
<datafield tag="084" ind1=" " ind2=" ">
<subfield code="a">873</subfield>
</datafield>
<datafield tag="245" ind1="1" ind2="2">
<subfield code="a">A Nine year follow up study of renal effects in workers exposed to cadmium in a zinc ore refinery</subfield>
<subfield code="c">N.J. van Sittert... [et al.]</subfield>
</datafield>
<datafield tag="520" ind1=" " ind2=" ">
<subfield code="a">Renal changes with time have been studied in 14 workers engaged in the production of cadmium in a zinc ore refinery. These workers were examined once a year in the period 1980 to 1985 and 13 of them also in 1989. Renal effects were assessed by the determination of urinary N-acetyl- -D-glucosaminaidase (NAG), 2-microglobulin, retinol binding protein, albumin, total protein, and serum creatinine concentrations and activity. The World Health Organisation recommended limit and The American Conference of Governmental Industrial Hygienists (1992-93) proposed limit of 5 g-g creatinine would provide a much largersafety margin, and could be regarded as an action point for increased health surveillance</subfield>
</datafield>
<datafield tag="650" ind1="1" ind2="1">
<subfield code="0">MAPA20080576615</subfield>
<subfield code="a">Medicina laboral</subfield>
</datafield>
<datafield tag="650" ind1="1" ind2="1">
<subfield code="0">MAPA20080619480</subfield>
<subfield code="a">Enfermedades profesionales</subfield>
</datafield>
<datafield tag="650" ind1="1" ind2="1">
<subfield code="0">MAPA20080540463</subfield>
<subfield code="a">Cadmio</subfield>
</datafield>
<datafield tag="650" ind1="1" ind2="1">
<subfield code="0">MAPA20080538071</subfield>
<subfield code="a">Zinc</subfield>
</datafield>
<datafield tag="650" ind1="1" ind2="1">
<subfield code="0">MAPA20080556112</subfield>
<subfield code="a">Refinerías</subfield>
</datafield>
<datafield tag="650" ind1="1" ind2="1">
<subfield code="0">MAPA20080596194</subfield>
<subfield code="a">Enfermedades renales</subfield>
</datafield>
<datafield tag="650" ind1="1" ind2="1">
<subfield code="0">MAPA20080565541</subfield>
<subfield code="a">Epidemiología</subfield>
</datafield>
<datafield tag="700" ind1="1" ind2=" ">
<subfield code="0">MAPA20080179342</subfield>
<subfield code="a">Sitter, N.J. van</subfield>
</datafield>
<datafield tag="740" ind1="0" ind2=" ">
<subfield code="a">British journal of industrial medicine</subfield>
</datafield>
<datafield tag="773" ind1="0" ind2=" ">
<subfield code="t">British journal of industrial medicine</subfield>
<subfield code="d">London and Margate</subfield>
<subfield code="g">nº 7, July 1993 ; p. 603-612</subfield>
</datafield>
</record>
</collection>